Tirzepatide

Tirzepatide

Tirzepatide is a dual GIP/GLP-1 receptor agonist studied for metabolic research. RaySunPeptide manufactures and supplies Tirzepatide for qualified research, laboratory, and B2B applications.

COA Verified

Product Details

Specifications

Purity≥98% (HPLC verified)
FormLyophilized powder
Packaging5mg / 10mg / 15mg / 20mg / 30mg / 40mg / 50mg / 60mg / 100mg / 120mg
StorageStore at -20°C, protect from light
Catalog No.TR5 / TR10 / TR15 / TR20 / TR30 / TR40 / TR50 / TR60 / TR100 / TR120

Research Overview

Tirzepatide is a dual glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptor agonist that has been studied in metabolic research. It has been investigated for its effects on glucose regulation through dual receptor activation, with published research examining its binding affinity at both GIP and GLP-1 receptors. Clinical studies have investigated its dose-dependent effects on metabolic parameters. RaySunPeptide supplies Tirzepatide for qualified research and laboratory applications.

Specification

Testing Info

HPLC, Mass Spectrometry

FAQs

What is Tirzepatide?

Tirzepatide is a dual GIP/GLP-1 receptor agonist studied for metabolic research. It has been studied in preclinical and laboratory research settings.

Does RaySunPeptide provide COA for Tirzepatide?

Yes, a Certificate of Analysis is available upon request for each batch.

What specifications are available?

Tirzepatide is available in 5mg / 10mg / 15mg / 20mg / 30mg / 40mg / 50mg / 60mg / 100mg / 120mg configurations.

0%

Purity

0+

Tests Conducted

0%

Client Satisfaction

0h

Shipping Time

Place Order

Product

Tirzepatide